Atlas Trials

Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals

Clinical trial NCT00001462 · COMPLETED

Trial details

NCT number
NCT00001462
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
COMPLETED
Study type
OBSERVATIONAL
EmphysemaLung Diseases, ObstructiveAlpha 1-Antitrypsin Deficiency
Start date
1995-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.